SmartCella enters agreement to advance Professor Johan Ericson’s research on cell replacement therapies for Parkinson’s disease
SmartCella granted new European patent for the Extroducer delivery platform
SmartCella beviljas nytt europeiskt patent för leveransplattformen Extroducer
XyloCor and SmartCella enter into license agreement for use of the Extroducer to administer novel gene therapy XC001 to the heart
SmartCella tecknar licensavtal med XyloCor avseende Extroducer för att leverera genterapin XC001 till hjärtat
SmartCella tar in 50 miljoner euro för att accelerera tillväxt och kommersialisering
SmartCella raises EUR 50 million to accelerate growth and commercialization
Senior life science and medical specialists join SmartCella’s Board of Directors
SmartCella strengthens team with Dr Ricardo Baptista as CTO
SmartCella AB appoints Oskar Steneryd as new CFO
Let’s pioneer the future of targeted therapies together